SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001338095-15-000069
Filing Date
2015-11-12
Accepted
2015-11-12 06:11:02
Documents
10
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrx0930201510-q.htm 10-Q 699887
2 EXHIBIT 31.1 nrx09302015exhibit311.htm EX-31.1 12075
3 EXHIBIT 31.2 nrx09302015exhibit312.htm EX-31.2 12168
4 EXHIBIT 32 nrx09302015exhibit32.htm EX-32 8320
  Complete submission text file 0001338095-15-000069.txt   3936426

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nrx-20150930.xml EX-101.INS 652431
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nrx-20150930.xsd EX-101.SCH 33636
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nrx-20150930_cal.xml EX-101.CAL 47081
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nrx-20150930_def.xml EX-101.DEF 169286
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nrx-20150930_lab.xml EX-101.LAB 461050
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nrx-20150930_pre.xml EX-101.PRE 271751
Mailing Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604
Business Address 3200 BEECHLEAF COURT SUITE 900 RALEIGH NC 27604 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36303 | Film No.: 151221151
SIC: 2834 Pharmaceutical Preparations